A new drug discovery and development company is taking root in Madison, and it will prevent more than a dozen skilled scientists here from losing their jobs. Nimble Therapeutics formed in April,...
In a Phase 2 clinical study of Cellectar's lead drug candidate on patients with blood plasma cell cancer, researchers recorded a 30 percent response rate in the first 10 patients...
Exact Sciences Corp. hasn’t finished building its second big laboratory building to process Cologuard tests for colorectal cancer but the Madison cancer diagnostics company already is planning for lab No....
Arrowhead Pharmaceuticals is getting a $25 million milestone payment from Janssen Pharmaceuticals, and the payment is coming sooner than expected. Arrowhead is headquartered in Pasadena, California, but its main employment base...
More than 100,000 people a month, on average, are being screened for colorectal cancer using Cologuard, the Madison company that makes the diagnostic test disclosed Tuesday. “Cologuard is changing how Americans...
WASHINGTON, D.C. – U.S. Senator Tammy Baldwin today announced $3 million in federal grant funding from the National Institutes of Health (NIH) for the Wisconsin Alzheimer’s Disease Research Center (WADRC)...
The MOMENTUM study -- which stands for Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac -- focuses on treatment with a machine called Elekta Unity. The goal is to...
On April 29, WisconsinEye interviewed Eric Borgerding, Wisconsin Hospital Association president and CEO, about Medicaid expansion. Borgerding discussed the current state of Wisconsin hospitals and how Governor Tony Evers' budget...
Stratatech, a Madison company with skin tissue to treat people with severe burns, is showing off its expanded quarters in University Research Park as it moves a step closer to...
The same aspects of rural life that are attractive to many Wisconsinites — solitude, space, smaller communities — can often make getting the health care they need a challenge that...